Tessier-Lavigne Marc 4

4 · Denali Therapeutics Inc. · Filed Jun 4, 2024

Form 4

Period: 2024-05-31

Director

Transactions

Award
Common Stock
2024-05-31+5,967→ 1,880,539 total
Award
Stock Option (right to buy)
2024-05-31+17,901→ 17,901 total
Exercise: $18.56Exp: 2034-05-31→ Common Stock (17,901 underlying)

Holdings

Footnotes (6)

[F1]Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.
[F2]Includes 5,967 unvested RSUs.
[F3]The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 1, for which the Reporting Person serves as trustee.
[F4]The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 2, for which the Reporting Person serves as trustee.
[F5]The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 3, for which the Reporting Person serves as trustee.
[F6]100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Documents

1 file